(This story was first published via NewsWise )
The Rutgers Cancer Institute of New Jersey has taken a significant step in cementing it’s pledge to support continued research in the fast-growing and life-changing field of precision medicine with the creation of the Omar Boraie Chair in Genomic Science. Endowments such as this one speak volumes to the prestigious university’s acknowledgement of and dedication to a level of academic discipline that is displayed only at the finest institutions of higher learning in the world. This action confirms the university’s promise to continue with it’s support toward the progression of this so-important field. The Chair’s name is in honor of New Brunswick developer Omar Boraie, who has pledged his support of the chair in the amount of $1.5 million. This incredibly generous donation highlights Rutgers’ “18 Chair Challenge”, a campaign in which every donation of $1.5 million made in support of each of the university’s 18 chairs will be matched dollar for dollar by a generous anonymous donor. This will make it possible for the campaign to raise an incredible $3 million per chair.
A young yet rapidly-growing and developing field, genomic science is already serving to change the face of cancer diagnosis in the medical field as well as how treatment is decided upon and undertaken. Genetic principles are applied to the more traditional methods of studying and treating malignant tumors. This provides Oncologists with a greater number of options with regard to customization of treatments and therapy plans with which they will be able to achieve a greater number of positive and life-saving results. President Barack Obama used his State Of The Union Address recently to announce the creation of a nationwide initiative which would concentrate solely on researching and developing cures for several life-threatening conditions, cancer being among the most prominent of those conditions. Called the Precision Medical Initiative, the initiative will further expand the ability of experts in the various fields to work more closely together to create these treatments and cures to save lives.
Gene sequencing is a science which is at the forefront of Rutgers Cancer Institute’s cancer studies, focusing on the early discovery and identification of tumors and subsequent effective patient care. The university holds the distinction of being one of the medical facilities in the United States to be at the forefront of utilizing this type of precision medical approach. This led to new methods of therapy – and successful treatment – for those who were stricken with many lesser-known cancers.
Omar Boraie’s impressive background in Chemistry as well as his avid interest in cancer research has led him to become one of the top developers in this field. His endowment and support of the Omar Boraie Chair in Genomic Science speaks to his dedication and humanity in the search for treatments of this disease.